quinoxalines has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calcutt, NA; Chaplan, SR | 1 |
| Barbe, P; Berlan, M; Estan, L; Guimbaud, R; Louvet, JP; Montastruc, JL; Senard, JM; Tran, MA | 1 |
2 other study(ies) available for quinoxalines and Diabetic Neuropathies
| Article | Year |
|---|---|
Spinal pharmacology of tactile allodynia in diabetic rats.
Topics: 2-Amino-5-phosphonovalerate; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Anti-Bacterial Agents; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Imidazoles; Injections, Spinal; Medetomidine; Morphine; Pain; Quinoxalines; Rats; Rats, Sprague-Dawley; Spinal Cord; Streptozocin | 1997 |
Decreased high affinity state in platelet alpha 2-adrenoceptors from diabetic patients with orthostatic hypotension.
Topics: Adrenergic alpha-Agonists; Adult; Blood Platelets; Brimonidine Tartrate; Cell Membrane; Diabetes Mellitus; Diabetic Neuropathies; Female; Glycated Hemoglobin; Humans; Hypotension, Orthostatic; Kinetics; Male; Middle Aged; Pressoreceptors; Quinoxalines; Receptors, Adrenergic, alpha; Yohimbine | 1990 |